英文別名 Vindoline free base; Bufexamacum; aspidospermidine-3-carboxylicacid,4-(acetyloxy)-6,7-didehydro-3-hydroxy-16-me; thoxy-1-methyl-,methylester,(2-beta,3-beta,4-beta,5-alpha,12-beta,19-alpha); vindolin; Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12beta,19alpha)-; (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(Acetyloxy)-6,7-didehydro-3-hydroxy-16-methoxy-1-methyl-aspidospermidine-3-carboxylic acid methyl ester; Vindoline Tartrate; methyl (2beta,3beta,4beta,5xi,12beta,19alpha)-4-(acetyloxy)-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate; methyl (2beta,3beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate; methyl (2beta,3beta,4beta,5alpha,19alpha)-4-(acetyloxy)-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate; methyl (2beta,4beta,5alpha,12beta,19alpha)-4-(acetyloxy)-3-hydroxy-16-methoxy-1-methyl-6,7-didehydroaspidospermidine-3-carboxylate.
關(guān)鍵字： 文朵靈;長春花朵靈;文朵靈堿;文多靈生產(chǎn)廠家;文多靈價(jià)格;
湖北邁科醫(yī)藥科技有限公司作為全球?qū)I(yè)的服務(wù)型醫(yī)藥貿(mào)易企業(yè)之一，公司凝聚了一支高素質(zhì)、具有國際化視野的經(jīng)營管理團(tuán)隊(duì)，并依托在藥證法規(guī)、商業(yè)模式、研發(fā)技術(shù)、綜合管理等方面的優(yōu)勢，在業(yè)內(nèi)樹立了良好口碑，已成為全球眾多上市藥企的醫(yī)藥定制研發(fā)生產(chǎn)服務(wù)合作伙伴。